By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


CBT Pharma 

5976 W. Las Positas Boulevard
Suite 208
Pleasanton  California  94588-8506  U.S.A.
Phone: 925-272-4090 Fax: 866-745-6215


CBT Pharma is an emerging life sciences oncology company focused on developing innovative medicines targeting the growth and proliferation of cancer cells for which available treatments are inadequate.

The company was founded in 2016 with headquarters in California with global partners and a subsidiary in Asia. Our pipeline is comprised of four development-stage assets – an oral agent that specifically targets cancer metastasis, a pre-clinical candidate that targets uncontrolled growth signaling pathways, and two investigational products that restore the body’s immune system to recognize and kill cancer cells.




Founders: Guo-Liang Yu and Sanjeev Redkar

CEO: Sanjeev Redkar, PhD, MBA

Executive Vice President and COO: Gavin Choy, PharmD, MBA


Please click here for CBT Pharma's Pipeline.

Key Statistics

Ownership: Private

Web Site: CBT Pharma

Company News
CBT Pharma Appoints Nationally Recognized Leaders In Oncology To Newly Established Scientific Advisory Board 8/28/2017 7:30:11 AM
CBT Pharma Presents Data Demonstrating Anti-Tumor Activity Of Its Highly Specific C-MET Inhibitor, Bozitinib (CBT-101), At AACR Annual Meeting 2017 4/4/2017 7:40:04 AM
CBT Pharma Release: First-in-Human Genolimzumab Phase I Study Initiated To Assess Safety And Preliminary Efficacy In Patients With Select Advanced Solid Tumors 3/30/2017 8:22:44 AM
CBT Pharma Presents Data Demonstrating Anti-Tumor Activity Of Its Programmed Death-1 Antibody, CBT-501, At ASCO-SITC Clinical Oncology Symposium 2/23/2017 7:34:12 AM
Bay Area’s CBT Pharma Plans to Launch 2 Phase I Trials in 2017 12/22/2016 11:02:37 AM
CBT Pharma Closes $9.75 Million Series A Financing Led By OrbiMed For Development Of Oncology Pipeline 8/29/2016 10:23:17 AM